7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,372.79

-18.95

-0.02%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

ASX - Delayed Quote AUD

Actinogen Medical Limited (ACW.AX)

0.0420 -0.0010 (-2.33%)

At close: October 30 at 4:10:11 PM GMT+11

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-November

GlobeNewswire 3d ago

ACW.AX
-2.33%
Actinogen receives $10.8 million R&D tax rebate as Xanamem results approach

Proactive 5d ago

ACW.AX
-2.33%
ATGGF
Actinogen Medical nears key XanaMIA trial readout - ICYMI

Proactive 9d ago

ACW.AX
-2.33%
ATGGF
Actinogen Medical enters ‘database lock’ to process XanaMIA’ data and confirm findings

Proactive 10d ago

ACW.AX
-2.33%
ATGGF
Small Cap Watch: Actinogen locks XanaMIA database and Kingfisher advances Broken Hill portfolio

Proactive 11d ago

ACW.AX
-2.33%
^AXSO

KGF.L
Actinogen Medical: XanaMIA results due in November

Proactive 12d ago

ACW.AX
-2.33%
Actinogen Medical closes September quarter with XanaMIA readout in sight

Proactive 13d ago

ACW.AX
-2.33%
ATGGF
Actinogen's Xanamem trial hits key milestone ahead of results - ICYMI

Proactive 30d ago

ACW.AX
-2.33%
ATGGF
Actinogen Medical's XanaMIA Alzheimer’s trial nears November results

Proactive 1mo ago

ACW.AX
-2.33%
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November

GlobeNewswire 1mo ago

ACW.AX
-2.33%
Actinogen Medical completes final XanaMIA patient visit; November Alzheimer’s trial results on track

Proactive 1mo ago

ACW.AX
-2.33%
ATGGF
Actinogen CEO explains Xanamem Alzheimer’s trial; eyes November milestone

Proactive 1mo ago

ACW.AX
-2.33%

Performance Overview

Return	ACW.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	-31.15%	+2.22%
1-Year	+20.00%	+0.29%
3-Year	+147.06%	+31.37%

Mobilize your Website

View Site in Mobile | Classic

Share by: